Gufic BioSciences Intrinsic Value
GUFICBIO Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹147.84 | ₹118.27 - ₹177.41 | -54.4% | EPS: ₹6.72, Sector P/E: 22x |
| Book Value Method | asset | ₹809.88 | ₹728.89 - ₹890.87 | +150.0% | Book Value/Share: ₹601.00, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹647.90 | ₹583.11 - ₹712.69 | +100.0% | Revenue/Share: ₹956.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹647.90 | ₹583.11 - ₹712.69 | +100.0% | EBITDA: ₹160.00Cr, EV/EBITDA: 10x |
| PEG Ratio Method | growth | ₹97.18 | ₹87.46 - ₹106.90 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹103.82 | ₹93.44 - ₹114.20 | -68.0% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹647.90 | ₹583.11 - ₹712.69 | +100.0% | ROE: 11.3%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹301.45 | ₹271.31 - ₹331.60 | -6.9% | EPS: ₹6.72, BVPS: ₹601.00 |
Want to compare with current market value? Check GUFICBIO share price latest .
Valuation Comparison Chart
GUFICBIO Intrinsic Value Analysis
What is the intrinsic value of GUFICBIO?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Gufic BioSciences (GUFICBIO) is ₹647.90 (median value). With the current market price of ₹323.95, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹97.18 to ₹809.88, indicating ₹97.18 - ₹809.88.
Is GUFICBIO undervalued or overvalued?
Based on our multi-method analysis, Gufic BioSciences (GUFICBIO) appears to be trading below calculated value by approximately 100.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 3.45 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.95 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 11.3% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 16.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.82x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Gufic BioSciences
Additional stock information and data for GUFICBIO
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹123 Cr | ₹88 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹-8 Cr | ₹-59 Cr | Negative Cash Flow | 3/10 |